Walgreens’ new gene and cell therapy business will operate under a newly launched segment called Walgreens Specialty Pharmacy, which was also announced today and now houses the company’s four ...

Gene and Cell Services Pharmacy and Innovation Center – Four central specialty pharmacies – Nearly 300 community-based specialty pharmacies across the nation – More than 1,500 specialty ...

Walgreens is expanding its specialty pharmacy services to offer gene and cell therapy services, supported by a dedicated 18,000-square-foot center in Pittsburgh, the company announced Thursday.

Walgreens said it will start working directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader effort to expand its specialty pharmacy services.

Walgreens Boots Alliance (NASDAQ:WBA) has expanded its specialty pharmacy services with a unit dedicated to gene and cell therapy services, the company announced late Wednesday. Effective Aug. 1 ...

Walgreens Specialty Pharmacy introduces a comprehensive suite of services, including gene and cell therapy solutions, marking a significant advancement in the company’s healthcare offerings.

"Discover Walgreens' expanded specialty pharmacy services, including gene and cell therapy, with over 1,500 trained pharmacists and 5,000 support team members." ...

Walgreens Specialty Pharmacy has more than 1,500 specialty-trained pharmacists, 5,000 patient advocacy support team members and ten dedicated Specialty360 teams that support all specialty ...

Originally published by Walgreens Boots Alliance Walgreens Specialty Pharmacy combines existing specialty assets, fully integrates AllianceRx and represents the company’s latest step to leverage its ...

Gene and Cell Services Pharmacy and Innovation Center — a dedicated 18,000-sq.-ft. center in Pittsburgh, Pa., with services and capabilities for these emerging therapies, including innovative ...

Gene and Cell Services Pharmacy and Innovation Center - a dedicated 18,000-square-foot center in Pittsburgh, PA, with services and capabilities for these emerging therapies, including innovative ...